Document Detail


Price subsidies increase the use of private sector ACTs: evidence from a systematic review.
MedLine Citation:
PMID:  24633915     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND Although artemisinin combination therapies (ACTs) are the recommended first-line treatment for uncomplicated malaria in most endemic countries, they have been prohibitively expensive in the retail sector where many suspected malaria cases purchase treatment. ACT subsidies seek to stimulate consumer demand for the drugs over cheaper but often ineffective alternatives by reducing their prices. Recent evidence from eight regions implementing such subsidies suggests that they are generally successful in improving availability of the drugs and decreasing their retail prices, but it remains unclear whether these outcomes translate to improved use by patients with suspected malaria. METHODS and findings A systematic literature review was conducted to identify reports of experimental or programmatic ACT subsidies to assess the impact of subsidies on consumer use. Relationships between price, use and potential confounding factors were examined using logistic and repeated measures binomial regression models, and approximate magnitudes of associations were assessed with linear regression. In total, 40 studies, 14 peer-reviewed and 26 non-peer-reviewed, were eligible for inclusion in the analysis. The reviewed studies found a substantial increase in private sector ACT use following the introduction of a subsidy. Overall, each $1 decrease in price was linked to a 24 percentage point increase in the fraction of suspected malaria cases purchasing ACTs (R(2) = 0.302). No significant differences were evident in this relationship when comparing the poorest and richest groups, rural vs urban populations or children vs adults. CONCLUSIONS These findings suggest that ACT price reductions can increase their use for suspected malaria, even within poorer, more remote populations that may be most at risk of malaria mortality. Whether a subsidy is appropriate will depend upon local context, including treatment-seeking behaviours and malaria prevalence. This review provides an initial foundation for policymakers to make evidence-based decisions regarding ACT price reductions to increase use of potentially life-saving drugs.
Authors:
Alexandra Morris; Abigail Ward; Bruno Moonen; Oliver Sabot; Justin M Cohen
Related Documents :
22548445 - Neonatal hemifacial spasm and fourth ventricle mass.
24633915 - Price subsidies increase the use of private sector acts: evidence from a systematic rev...
17430615 - Principles and practice in ethical review of animal experiments across europe: summary ...
19000355 - Successful treatment of pediatric stroke with recombinant tissue plasminogen activator ...
9930145 - Inhibin is not an immunohistochemical marker for hepatocellular carcinoma. an example o...
2409665 - Adenosquamous carcinoma of the ileum. report of a case and review of the literature.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-14
Journal Detail:
Title:  Health policy and planning     Volume:  -     ISSN:  1460-2237     ISO Abbreviation:  Health Policy Plan     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8610614     Medline TA:  Health Policy Plan     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contextual factors as a key to understanding the heterogeneity of effects of a maternal health polic...
Next Document:  Inhibition of palmitate-induced GADD34 expression augments apoptosis in mouse insulinoma cells (MIN6...